Scarica l'app Stockscreener
1.34
13.56%
0.16
Dopo l'orario di chiusura:
1.34
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PYXS Giù?
Forum
Previsione
Precedente Chiudi:
$1.18
Aprire:
$1.16
Volume 24 ore:
2.00M
Relative Volume:
3.60
Capitalizzazione di mercato:
$83.01M
Reddito:
-
Utile/perdita netta:
$-73.79M
Rapporto P/E:
-0.7283
EPS:
-1.84
Flusso di cassa netto:
$-77.44M
1 W Prestazione:
+14.53%
1M Prestazione:
+4.69%
6M Prestazione:
-16.25%
1 anno Prestazione:
-64.46%
Intervallo 1D:
$1.16
$1.38
Intervallo di 1 settimana:
$1.12
$1.38
Portata 52W:
$0.8332
$5.3899
Pyxis Oncology Inc Stock (PYXS) Company Profile
Nome
Pyxis Oncology Inc
Settore
Industria
Telefono
(617) 221-9059
Indirizzo
321 HARRISON AVENUE, BOSTON
Confronta PYXS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PYXS
Pyxis Oncology Inc
|
1.34 | 73.10M | 0 | -73.79M | -77.44M | -1.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Pyxis Oncology Inc Stock (PYXS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-11-08 | Iniziato | Stephens | Overweight |
| 2024-08-08 | Iniziato | Stifel | Buy |
| 2024-05-07 | Ripresa | Jefferies | Buy |
| 2024-02-09 | Iniziato | BTIG Research | Buy |
| 2024-01-23 | Iniziato | Leerink Partners | Outperform |
| 2023-09-05 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-11-02 | Iniziato | BofA Securities | Neutral |
| 2021-11-02 | Iniziato | Credit Suisse | Outperform |
| 2021-11-02 | Iniziato | Jefferies | Buy |
Mostra tutto
Pyxis Oncology Inc Borsa (PYXS) Ultime notizie
What analysts say about Pyxis Oncology Inc. stockHigh-margin investment plays - Autocar Professional
Pyxis Oncology Inc’s: Contrasting Stock Performances in a Volatile Market - investchronicle.com
Can Pyxis Oncology Inc. stock recover from recent declineFree Predictions - jammulinksnews.com
Pyxis Oncology Inc. Stock Analysis and ForecastFree Stock Movement Tracking - jammulinksnews.com
Is Pyxis Oncology Inc. a good long term investmentRecord-setting profit potential - jammulinksnews.com
What drives Pyxis Oncology Inc. stock priceFree Smart Trading Workshop - jammulinksnews.com
Financial Review: Ainos (NASDAQ:AIMD) vs. Pyxis Oncology (NASDAQ:PYXS) - Defense World
what makes pyxis oncology inc. stock price move sharplyGrowth Optimized Stock Radar - Newser
Why Pyxis Oncology Inc. stock attracts strong analyst attentionFree Low-Risk Investment Plans - Newser
How Pyxis Oncology Inc. stock performs during market volatilityDaily Trade Opportunity - Newser
What makes Pyxis Oncology Inc. stock price move sharplyFree Access to Stock Community - Newser
Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives $9.00 Average Price Target from Analysts - Defense World
Pyxis Oncology (NASDAQ:PYXS) Stock Price Up 3.6% – Time to Buy? - Defense World
Pyxis Oncology Appoints New Principal Financial Officer - The Globe and Mail
Pyxis Oncology announces retirement of CFO and COO Pamela Connealy By Investing.com - Investing.com South Africa
Pyxis Oncology, Inc. Announces CFO Changes, Effective July 1, 2025 - MarketScreener
Pyxis Oncology announces retirement of CFO and COO Pamela Connealy - Investing.com
Pyxis Oncology's Equity Incentives: A Strategic Gambit for Clinical Success? - AInvest
Pyxis Oncology, Inc.(NasdaqGS: PYXS) dropped from Russell 3000 Index - MarketScreener
Pyxis Oncology, Inc.(NasdaqGS: PYXS) dropped from Russell 2000 Index - MarketScreener
Pyxis Oncology, Inc.(NasdaqGS: PYXS) dropped from Russell 2000 Dynamic Index - MarketScreener
Pyxis Oncology Inc (PYXS) Stock: Navigating a Year of Stock Volatility - investchronicle.com
Pyxis Oncology Insiders Lose Out As Stock Sinks To US$1.14 - Yahoo Finance
Pyxis Oncology shareholders elect three directors at annual meeting - Investing.com
Pyxis Oncology Elects New Directors at Annual Meeting - TipRanks
Pyxis Oncology Inc Azioni (PYXS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):